The Fed’s overnight target rate cuts have failed to suppress long-duration yields, creating buying opportunities at the long ...

CUDA faces new chip rivals, HBM supply, and data-center power becomes AI bottlenecks. Click to read more on NVDA.

UnitedHealth beats Q2 2026, raises EPS guidance, and expands Optum margins. Click to read about what it means for ...

B PayPal bid suggests undervalued EV/Sales and strong FCF, but weak FY2026 guidance adds risk. Click here to read more.

Chevron offers a compelling buy as oil inventories are at multi-decade lows, providing a structural floor under crude prices.

Buy iShares Russell 2000 Value ETF: cyclical tailwinds, strong fundamentals, attractive valuations, and low fees. Click here ...

Neutral on iShares MSCI Indonesia ETF: cheap 8.7x P/E but weak trend, heavy financials, low growth, and EM risk. Click here ...

Tesla, Inc.’s “Musk premium” and Q2 earnings outlook—plus robotaxi and Optimus catalysts, risks, and long-term AI moat. Click ...

Vistry faces UK affordable-housing tailwinds, but rising funding delays, cost overruns, and tighter liquidity may force ...

XLV may offer storm shelter as tech weakens, but valuations look rich and upside may be limited this cycle. Click here to ...

Revisit Neuronetics with updates on operations, financial performance, and outlook. Click to read how recent developments ...

NNN REIT update: disciplined self-funded growth, $200M capital recycling, 98.6% occupancy, and yield below 5%—see why it’s a ...